Skip to main content

Animations

MJFF Publications

4411 - 4420 of 6295 Results
Title
Year
  • Year
  • 2014
  • 2015
  • 2016
  • 2019
  • 2023
  • 2021
  • 2014
  • 2022
  • 2025
  • 2016
  • Summary Details
    OPEN
    Title: Cadherin‐8 expression, synaptic localization, and molecular control of neuronal form in prefrontal corticostriatal circuits
    Journal Name: Journal of Comparative Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/cne.23666
    Citation Count: 40
  • Summary Details
    OPEN
    Title: CSF tau and tau/Aβ42 predict cognitive decline in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.12.027
    Citation Count: 91
  • Summary Details
    OPEN
    Title: Neuroimmunology of the Interleukins 13 and 4
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci6020018
    Citation Count: 102
  • Summary Details
    OPEN
    Title: Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.001
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson’s Disease Models
    Journal Name: Antioxidants
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/antiox12030582
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26094
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Combining biomarkers for prognostic modelling of Parkinson’s disease
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2021-328365
    Citation Count: 24
  • Summary Details
    OPEN
    Title: An Experimental Approach for Investigating Freezing of Gait in Parkinson’s Disease Using Virtual Reality and Neural Sensing: A Pilot Study
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s25134036
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0072-9
    Citation Count: 239
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.